![Melissa Downs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Melissa Downs is currently Executive Director-External Communications at Lantheus Holdings, Inc. since 2025.
Formerly, Ms. Downs worked at Progenics Pharmaceuticals, Inc. as Investor Relations Contact.
Melissa Downs active positions
| Companies | Position | Start |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 2020-07-31 |
Former positions of Melissa Downs
| Companies | Position | End |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Lantheus Holdings, Inc.
 Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
- Stock Market
- Insiders
- Melissa Downs
